A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients At High Risk for Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

330

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Breast Neoplasm

Interventions

DIAGNOSTIC_TEST

ExoPred

Performing in vitro diagnostics with devices developed by EXoPERT

Trial Locations (2)

RECRUITING

Korea University Anam Hospital, Seoul

RECRUITING

Korea University Guro Hospital, Seoul

All Listed Sponsors

lead

EXoPERT

INDUSTRY